Andrew Joseph
Reporter at STAT
Reporter at @statnews, covering health and medicine out of Europe. Past: SA Express-News, SF Chronicle. [email protected]
Articles
-
1 week ago |
statnews.com | Andrew Joseph
LONDON — The European Commission on Monday unveiled a roughly $565 million package to retain and attract scientists, as other countries try to leverage the Trump administration’s dismantling of research programs in the U.S. to build up their own enterprises.
-
1 week ago |
statnews.com | Andrew Joseph
MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts. The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.
-
2 weeks ago |
statnews.com | Andrew Joseph
A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its enrollment target, ahead of expectations. The Phase 3 study of the M72/AS01E vaccine, which is taking place at 54 sites across five countries, started delivering shots to volunteers last March.
-
2 weeks ago |
statnews.com | Andrew Joseph
After months of discussion, Germany’s Merck KGaA said Monday it would buy SpringWorks Therapeutics for $47 a share in cash, a deal with an equity value of nearly $4 billion. The acquisition was in many ways expected. Merck had said publicly it was negotiating with SpringWorks after media reports on the subject, including in the Wall Street Journal last week.
-
3 weeks ago |
statnews.com | Andrew Joseph
The hulking factories are tucked away off the roads around the village of Ringaskiddy — operated by the likes of Pfizer, Johnson & Johnson, and BioMarin, whose plant featured signs last week touting a new facility “coming Q1 2027.”The nearby town of Carrigtwohill crows that it’s grown “+400% over the past 20 years,” a surge driven by sites run by GSK, AbbVie, and Gilead.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 6K
- Tweets
- 3K
- DMs Open
- Yes
RT @HelenBranswell: Big news today: @BillGates will wind down the @gatesfoundation in 2045, earlier than previously planned, with accelerat…
RT @matthewherper: New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff https://t.co/BT3N0C0VH3
RT @LizzyLaw_: People looking for roles in gov't are often hesitant to share their opinions. Not Vinay Prasad. Here's a compilation of the…